Streetwise Articles


15 Reasons Why Hemp Producer Elixinol Should Be in Your Portfolio

Contributed Opinion
  ()
With the U.S. government legalizing hemp in the recently passed 2018 Farm Bill, Fincom Investment Partners profiles a hemp company whose largest market is the U.S. read more >

Small-Cap Firm Announces Major Medical Technology Acquisition

Contributed Opinion
  ()
Ron Struthers of Struthers Resource Stock Report profiles an innovative medical firm in Canada that just announced the acquisition of a medical technology firm, a move that will expand its reach across Canada. read more >

Telehealth Services Provider's Positive Q3/18 Results Reflect 'Robust Growth Rate'

Research Report
  ()
A William Blair report reviewed the firm's operational and financial numbers for the period. read more >

Coverage Initiated on Tech Firm Servicing Healthcare Industry

Research Report
  ()
Haywood Securities presented the thesis for investment in this company, including its growth drivers and continued focus on acquisition. read more >

Health Stock 'Looking Set to Bounce Back After 90% Drop'

Contributed Opinion
  ()
Technical analyst Clive Maund charts a telemedicine technology company and explains why he believes the company's stock should rebound. read more >

Strong Health Stock 'Ready to Commence New Upleg'

Contributed Opinion
  ()
Technical analyst Clive Maund analyzes a rapidly expanding company with medical clinics in British Columbia that is using advanced technology and AI. read more >

Small-Cap Company Could Be the Face of the Future of Medicine

  ()
A company in Canada that is changing the paradigm for providing healthcare in Canada and potentially elsewhere by integrating technology and artificial intelligence has just announced a major acquisition. read more >

Biotech Delivers Positive Study Results for Prostate Cancer Prognostic Test

Research Report
  ()
An H.C. Wainwright & Co. report reviewed this firm's latest news concerning a data readout, trial approval and therapeutic application. read more >

Precision Medicine Developer Secures Another Patent for Drug Candidate

Research Report
  ()
This company takes a step forward in its efforts to protect its intellectual property. read more >

Biotech to Lead dMAB Tech Field with First Clinically Tested Product

Research Report
  ()
An H.C. Wainwright & Co. report discussed recent articles covering results of this firm's preclinical studies. read more >

Neuromonitoring Stock 'Ready to Rally'

Contributed Opinion
  ()
Technical analyst Clive Maund charts a neuromonitoring company that he believes is undervalued. read more >
News Update

Cannabis Provider to Debut Five More Dispensaries in Florida

News Update
  ()
This company plans to add even more this year as well. read more >

Biopharma Agrees to $215 Million Acquisition Deal

Research Report
  ()
An H.C. Wainwright & Co. report detailed the terms of the definitive agreement concerning the merger. read more >
News Update

Biopharma to Accelerate Trial Timeline with Amendment

News Update
  ()
The change relates to the onset of dosing for patients with different degrees of disease. read more >
News Update

Biotech Ramps Up Philippine Sales of Livestock Feed Premix

News Update
  ()
A distributor of the proprietary product places a third large order. read more >
News Update

Life Science Company Addresses Antibiotic Resistance Problem

News Update
  ()
This firm's proprietary technology provides an alternative to antibiotic use in livestock production. read more >
News Update

Biotech Files Patent Application for Nitric Oxide Delivery Device

News Update
  ()
With this development, the company advances blood/plasma transfusion technology. read more >

Imprimis: Priming the Pumps for a Big 2019

Contributed Opinion
  ()
Daniel Carlson of Tailwinds Research profiles a biotech company he is bullish on. read more >

Catalysts Approaching for U.S. Developer of Cancer Therapeutics

Research Report
  ()
An H.C. Wainwright & Co. report highlighted this biotech's upcoming key events to watch. read more >

Biotech Announces Preclinical Data on its Intravaginal Rings at Meeting

Research Report
  ()
A ROTH Capital Partners report relayed the contents of both presented abstracts. read more >

Target Price Raised on Biotech in Anticipation of Clinical Trial Presentation

Research Report
  ()
An H.C. Wainwright & Co. report discussed what investors might expect to hear from the company regarding its cholesterol-lowering therapy. read more >
News Update

Selectively Targeting Alzheimer's Disease's Root Cause Is Key, Biotech Says

News Update
  ()
This firm explains how its 15 years in drug development led to and supports this conclusion. read more >
News Update

Coverage Initiated on Developer of Targeted Gene Therapies for Cancer

Research Report
  ()
A LifeSci Capital report highlighted the advantages of this biotech story's lead candidate targeting bladder cancer. read more >

Hemp Sales Grow at CV Sciences: Q3 Beats Estimates, 2019 Outlook

Contributed Opinion
  ()
Fincom Investment Partners takes a look at Q3 earnings for a U.S.-based CBD company and explains why it believes it offers good value. read more >

A Canadian Cannabis Company for the Next Wave

Contributed Opinion
  ()
Ron Struthers, who believes the ideal marijuana stock to buy at this time is one that is focused on cannabis oil, profiles one such company that he sees as undervalued. read more >
Showing Results: 1 to 25 of 97 Next

Get Our Streetwise Reports Life Sciences Report Newsletter Free and be the first to know!

A valid email address is required to subscribe

More Experts